IS DARATUMUMAB ELIMINATED IN THE URINE OF PATIENTS WITH AL AMYLOIDOSIS?

被引：0
|
作者：
Gil Alos, D. [1 ]
Cuevas Gomez, D. [2 ]
Colmenares Gil, R. [1 ]
Gil Manso, R. [1 ]
Iniguez Garcia, R. [1 ]
Zamanillo Herrero, I [1 ]
Poza Santaella, M. [1 ]
Puerta Fonolla, P. [2 ]
Sanchez Pina, J. M. [1 ]
Martinez Lopez, J. [1 ]
机构：
[1] Hosp 12 Octubre, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Hosp 12 Octubre, Serv Bioquim & Anal Clin, Madrid, Spain
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-030
引用
下载
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [1] Daratumumab for AL amyloidosis
    Allison S.
    Nature Reviews Nephrology, 2021, 17 (9) : 572 - 572
  • [2] Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis
    Rosko, Nathaniel
    Mo, Hanjie
    Rudoni, Joslyn
    Siebenaller, Caitlin
    Lee, Sarah S.
    Chakraborty, Rajshekar
    Faiman, Beth M.
    Khouri, Jack
    Garcia, Alex V. Mejia
    Samaras, Christy J.
    Anwer, Faiz
    Valent, Jason
    BLOOD, 2019, 134
  • [3] Daratumumab for the treatment of AL amyloidosis
    Sidiqi, M. Hasib
    Gertz, Morie A.
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 295 - 301
  • [4] TREATMENT WITH DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA ASSOCIATED AL AMYLOIDOSIS
    Fazio, F.
    Basset, M.
    Milani, P.
    Foli, A.
    Nuvolone, M.
    Foa, R.
    Petrucci, M. T.
    Merlini, G.
    Palladini, G.
    HAEMATOLOGICA, 2019, 104 : 11 - 11
  • [5] Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab
    Szalat, Raphael E.
    Gustine, Joshua
    Sloan, J. Mark
    Edwards, Camille, V
    Sanchorawala, Vaishali
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (01) : 79 - 89
  • [6] Daratumumab-based therapies in patients with AL amyloidosis.
    Abeykoon, Jithma P.
    Zanwar, Saurabh
    Kumar, Shaji
    Dispenzieri, Angela
    Rajkumar, S. Vincent
    Lacy, Martha
    Dingli, David
    Leung, Nelson
    Muchtar, Eli
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Buadi, Francis
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis
    Milani, Paolo
    Fazio, Francesca
    Basset, Marco
    Berno, Tamara
    Larocca, Alessandra
    Foli, Andrea
    Riva, Marcello
    Oliva, Stefania
    Ripepi, Jessica
    Nuvolone, Mario
    Petrucci, Maria Teresa
    Merlini, Giampaolo
    Palladini, Giovanni
    BLOOD, 2019, 134
  • [8] Role of Daratumumab in Cardiac AL Amyloidosis
    Gertz, Morie A.
    JACC: CARDIOONCOLOGY, 2022, 4 (04): : 488 - 490
  • [9] Use of daratumumab in patients with amyloidosis
    Anzai, Adriano
    Utino, Armelin
    Katayama, Haroldo
    Spir, Ighor A. Z.
    Lemos, Marcio A.
    Anhesini, Mauricio
    Tiezzi, Oswaldo S.
    Spir, Patricia R. N.
    Otani, Pericles
    Bernardo, Wanderley M.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (11): : 1468 - 1471
  • [10] Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis
    Hassan, Hamza
    Anwer, Faiz
    Javaid, Anum
    Hashmi, Hamza
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
12345